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Dynamic coronary stenoses may be the cause of a variable angina 
threshold and rest angina in patients with chronic stable angina. It 
has been suggested that eccentric but not concentric coronary 
artery stenoses have the potential for dynamic changes of caliber 
in response to vasoactive stimuli. The vasomotor response of 
eccentric (asymmetric narrowing) and concentric (symmetric nar-
rowing) coronary stenoses to ergonovine (20 pg intra coronary or 
300 pg intravenous) and isosorbide dinitrate (1 mg intracoronary) 
was studied in 51 patients with chronic stable angina. Diameter of 
reference segments (angiographically normal segments proximal 
to the stenoses) and that of eccentric (n = 30) and concentric (n = 
35) coronary stenoses that ranged from 50% to 90% luminal 
diameter reduction were measured by computerized quantitative 
angiography before and after ergonovine and isosorbide dinitrate. 
Ergonovine reduced stenosis diameter (by 2:10%) in 80% of 
eccentric stenoses and 42% of concentric stenoses (p < 0.05). 
Mean (± SEM) diameter reduction with ergonovine was 19 ± 3% 
It has become apparent (1-4) that a large proportion of 
patients with chronic stable angina have a variable threshold 
for the provocation of their exertional angina and may also 
have angina at rest or with levels of exertion usually well 
tolerated by the patient. It has been suggested (1-7) that this 
is caused by episodic coronary vasoconstriction superim-
posed on critical atheromatous coronary obstructions. Sev-
eral studies (6,8-13) have documented the ability of coro-
nary stenoses to alter their caliber dynamically in response 
to vasoactive stimuli. It has been suggested that eccentric 
stenoses, which retain a variable arc of disease-free wall 
(14,15), but not concentric lesions (16), in which the athero-
sclerotic plaque involves the entire circumference of the 
artery, have the potential to dilate in response to nitrates and 
calcium channel antagonists. It has been proposed (6,10,17) 
that subtle variations of coronary tone at the site of signifi-
cant eccentric stenoses may cause marked changes in the 
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and 9.5 ± 2% for eccentric and concentric stenoses, respectively 
(p < 0.05). Isosorbide dinitrate increased coronary diameter (by 
~10%) in 70% of eccentric and 43% of concentric stenoses (p < 
0.05). Mean diameter of eccentric stenoses increased from 1.15 ± 
0.05 to 1.35 ± 0.06 mm after nitrate (18.6 ± 2.5%), whereas 
diameter of concentric stenoses increased from 1.05 ± 0.05 to 
1.14 ± 0.05 mm (10 ± 2.5%) (p < 0.05). Average dilation of 
reference segments with administration of isosorbide dinitrate and 
constriction with ergonovine were not significantly different in 
patients with concentric and eccentric stenoses. 
Thus, in patients with chronic stable angina, both eccentric 
and concentric stenoses have the potential for dynamic changes of 
caliber in response to vasoactive stimuli. However, a significantly 
larger proportion of eccentric stenoses exhibit this potential. The 
magnitude of dynamic changes of caliber is also larger in eccentric 
than in concentric stenoses. 
(J Am Coil CardioI1991;17:627-33) 
luminal caliber of the vessel and critical impairment of 
coronary blood flow. 
In chronic stable angina, it has been hypothesized 
(6,10,14-16) that the increment of coronary vasomotor tone 
that may cause a variable anginal threshold, with chest pain 
at levels of exertion usually well tolerated by the patient and 
occasional angina at rest, occurs at the site of eccentric 
stenoses. We studied the response of eccentric and concen-
tric coronary stenoses to the administration of ergonovine or 
intracoronary isosorbide dinitrate, or both, in patients with 
chronic stable angina. 
Methods 
Study patients (Table 1). Fifty-one of 62 consecutive 
patients with a history of chronic stable angina referred to 
our institution over a period of 5 months (February to June 
1989) for coronary arteriography were included in the study. 
Of the other 11 patients, 3 had angiographically normal 
coronary arteries and 8 declined to participate in the study. 
All 51 participating patients had chronic stable exertional 
angina, defined as typical effort angina relieved by rest or 
nitrates, with no change in symptoms in the 6 months 
preceding admission to the study, and angiographically 
documented coronary artery disease (intraluminal coronary 
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Table 1. Clinical and Angiographic Characteristics of 51 Patients 
With Chronic Stable Angina 
Age (yr) 
Gender 
Men 
Women 
Previous myocardial infarction 
Angina 
Exertional. with fixed threshold 
Mixed 
Coronary arteriography 
I vessel disease 
2 vessel disease 
3 vessel disease 
Stenosis morphology (no. of pts.) 
Concentric 
Eccentric 
Both types 
36 to 73 
39 
12 
12 
13 
38 
16 
24 
II 
23 
20 
8 
mean ± SO 
(56 ± II) 
(26%) 
(74%) 
(31%) 
(47%) 
(22%) 
(45%) 
(39%) 
(16%) 
diameter reduction :2:50% of at least one major coronary 
artery). Thirty-eight (74%) of the 51 patients had exercise-
induced angina with a variable and unpredictable threshold 
for the provocation of chest pain ("mixed angina," as 
defined by Stone et al. [4]), including the presence of angina 
during very minimal effort, usually well tolerated by the 
patient; of these, 19 also had a :2:6 month history of occa-
sional anginal episodes occurring at rest. Only 13 patients 
had effort angina with a fixed anginal threshold (a similar 
amount of exercise consistently and predictably producing 
angina). Patients with variant angina, unstable angina or 
myocardial infarction within 12 weeks were not considered 
for study. All patients had a positive exercise test response, 
with :2:0.1 m V of horizontal or downsloping ST segment 
depression. Twelve patients had had a myocardial infarction 
1 to 5 years before admission to the study. Clinical and 
angiographic characteristics of patients included in the study 
are summarized in Table 1. 
Study protocol. In every patient all antianginal medica-
tion was discontinued before the study, with the exception of 
sublingual nitrates, which were allowed for relief of anginal 
episodes. Nitrates and calcium channel antagonists were 
discontinued 48 hours before the study, and beta-adrenergic 
blockers at least 72 hours before the study. All patients were 
fasting, had not smoked and had not received sublingual 
nitrates for acute pain for at least 8 hours before cardiac 
catheterization. After diagnostic coronary arteriography, 
orthogonal views of the coronary arteries with stenotic 
lesions (:2:50%) were obtained before administration of er-
gonovine and nitrates (control coronary arteriograms). Er-
gonovine was given to the first 20 patients included in the 
study, irrespective of type of angina (20 Jlg intracoronary in 
6, and 300 Jlg intravenous in 14); coronary injections were 
repeated 3 to 4 min after ergonovine administration or earlier 
if angina or ST segment depression developed. In four 
patients angina or 1 mm of ST segment depression, or both, 
developed in response to ergonovine; these conditions rap-
idly resolved with administration of intracoronary nitrates. 
Intracoronary isosorbide dinitrate (1 mg) was adminis-
tered to all patients; in 31 as the only vasoactive stimulus, 
after the control arteriogram, and in 20 after administration 
of ergonovine. In the four patients in whom angina or ST 
segment depression, or both, developed with ergonovine, 
isosorbide dinitrate was administered immediately; in the 
other 16 patients isosorbide dinitrate was given after a 
second control angiogram, which was obtained 5 to 7 min-
utes after ergonovine. Therefore, control coronary angio-
grams were obtained before the administration of nitrate in 
every patient, with the exception of the four who required 
nitrates for the relief of ergonovine-induced ischemia; in 
these patients baseline diameter was used as control for both 
ergonovine and nitrate administration. In all patients coro-
nary arteriography was repeated 2 to 4 min after nitrate 
administration to assess its effect on coronary artery steno-
ses and reference segments. Sixty-five of 102 coronary 
stenoses observed in these patients were suitable for analy-
SIS. 
Every patient gave written informed consent before study 
entry. The study protocol was approved by the hospital's 
ethics committee. 
Coronary arteriography. The Judkins technique was 
used for coronary arteriography in all patients. In every case 
diagnostic arteriography was carried out using standard 
views; then, each coronary artery was selectively imaged in 
at least two orthogonal projections. An angiographically 
normal proximal. juxtaposed segment (reference segment) 
was used to determine the percent stenosis of the diseased 
segment. A stenosis was considered critical if intraluminal 
coronary diameter was reduced by :2:50%. Sixteen patients 
had one vessel, 24 had two vessel and II had three vessel 
disease (Table 1). 
Measurement of coronary diameters and assessment of 
stenosis morphology. Our technique of measuring coronary 
artery diameter has been reported previously (18). Briefly, 
coronary luminal diameter was measured by an automated 
edge contour detection computerized system (Coronary 
Angiography Analysis System [CAAS], Pie Data Medical). 
The size of the stem of the Judkins coronary catheter was 
used for calibration to determine absolute measurement in 
millimeters and correction was made for radiographic pin-
cushion distortion. Coronary arteriograms were analyzed by 
two independent observers and reanalyzed much later, with-
out knowledge of previous assessments, to determine repro-
ducibility of the method. No significant difference in the 
variances between analyses was found. 
Coronary stenoses were morphologically classified as 
concentric or eccentric by two independent observers, on the 
basis of qualitative analysis of every lesion in at least two 
orthogonal projections. Concentric stenoses were those pro-
ducing symmetric narrowing of a coronary artery. The 
borders of these lesions were smooth and their appearance 
was identical or almost identical in orthogonal projections. 
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Table 2. Response of 35 Concentric and 30 Eccentric Stenoses to Isosorbide Dinitrate and Ergonovine in 51 Patients With Chronic 
Stable Angina 
Baseline Isosorbide Baseline 
Diameter Dinitrate Diameter Diameter Ergonovine Diameter 
Type of Stenosis (mm) (mm) Change ('7<) (mm) (mm) Change (%) 
Concentric (n = 35) 1.05 ± 0.05 1.14 ± 0.05 
Eccentric (n = 30) 1.15 ± 0.05 1.35 ± 0.06 
Eccentric stenoses were asymmetric narrowings of a coro-
nary artery. Borders were smooth or irregular in these 
lesions and no attempt was made to further subdivide 
asymmetric lesions. Discrepancies arose in five patients. and 
the lesions were classified by consensus. The reproducibility 
for classifying a stenosis in its morphologic subset was 
determined by repeat evaluation of all films without knowl-
edge of the first reading. Ninety-two percent of all stenoses 
were read in an identical fashion; 8% were classified by 
consensus after the second reading. The qualitative classifi-
cation of stenosis type given by the two observers was 
compared with computerized stenosis symmetry measure-
ments of the same coronary lesions carried out with an 
automatic edge detection system (CAAS system) (19). Sixty-
two (95%) of the 65 stenoses were classified in an identical 
fashion both by the two independent observers and by the 
computer system. If the intraluminal diameter of stenoses 
changed by ~10% from the value control in response to 
isosorbide dinitrate or ergonovine. they were considered 
"dynamic. " 
The percent change in coronary artery diameter was 
calculated as follows: Percent vasoconstriction by ergo-
novine = {(Control diameter - diameter after ergonovine)/ 
Control diameter} x 100 (%). Percent vasodilatation by 
nitrate = {(Diameter after nitrate - Control diameter)/ 
Control diameter} x 100 (%). 
Data analysis. Data are presented as mean values ± 
SEM. Differences between proportions were analyzed by 
the Yates corrected chi-square test. Paired and unpaired 
Student's t tests were used to analyze continuous data. A p 
value < 0.05 was considered significant. 
Results 
Stenosis morphology (Table 1). Sixty-five (64%) of 102 
coronary artery stenoses (35 concentric and 30 eccentric) 
observed in these 51 patients were suitable for quantitative 
analysis, and results reported here refer to these stenoses. 
Twenty-three (45%) of the 51 patients had concentric sten-
oses only, 20 (39%) had eccentric stenoses only. and eight 
(16%) had both concentric and eccentric stenoses. Severity 
of coronary stenoses for the whole group ranged from 50% to 
95% (mean 75 ± 3%) luminal diameter reduction; the latter 
was not significantly different in concentric and eccentric 
stenoses (74 ± 2% and 75 ± 2.5%. respectively). 
Response of eccentric and concentric stenoses to ergonovine 
(Table 2). Mean aortic pressure and heart rate did not 
10.0 ± 2.50 1.13±O.07 0.99 ± 0.07 9.50 ± 2.0 
18.6 ± 2.50 1.22 ± 0.10 0.99 ± 0.10 19.0 ± 3.0 
change after intracoronary ergonovine but increased by 
5 mm Hg with intravenous ergonovine. Four of the 20 
patients (two with concentric and two with eccentric steno-
ses) who underwent ergonovine testing had ST segment 
depression. three of whom had angina. Symptoms and 
electrocardiographic (ECG) changes were promptly relieved 
by administration of intracoronary nitrates. None of the four 
patients had coronary artery occlusion with ergonovine, but 
all showed mild diffuse coronary constriction within the 
range observed in the whole group. In these patients luminal 
diameter of eccentric stenoses decreased more significantly 
than that of concentric stenoses (20.2 ± 4% versus 11.4 ± 
2.5%). Baseline stenosis severity was not significantly larger 
in these four patients than in the 16 who did not have 
symptoms with ergonovine (80 ± 3 versus 76 ± 4%, respec-
tively). Three had three vessel and one patient had two 
vessel disease; their exercise tolerance was significantly 
lower than that of the other patients receiving ergonovine. 
With ergonovine eight (57%) of 14 reference segments to 
concentric stenoses and six (60%) of 10 reference segments 
to eccentric stenoses had a luminal diameter reduction of at 
least ~ 10% (p = NS). Average coronary constriction was 
similar in the reference segments to eccentric and concentric 
stenoses (10.3 ± 2% and 10.6 ± 2%. respectively) (Fig. 1). 
A significantly larger proportion of eccentric than con-
centric stenoses were constricted by > /0% with ergonovine 
(80 l'erSliS 42%. respectively) (Fig. 2). Concentric stenoses of 
50% to 70% luminal diameter reduction had a degree of 
constriction after ergonovine similar to that of stenoses with 
more than 70% reduction (10.9 ± 3.5% and 9.2 ± 3%. 
respectively); a similar response was observed in eccentric 
coronary stenoses (12 ± 4 and 18 ± 4%. respectively, p = 
Figure 1. Diameter change of reference segments with the adminis-
tration of isosorbide dinitrate (ISDN) and ergonovine. The response 
of reference segments to these two vasoactive agents was not 
significantly different. 
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Figure 2. Dynamic behavior of eccentric and concentric stenoses in 
response to ergonovine and isosorbide dinitrate. A significantly 
larg~r pr~portion of ecc~ntric than of concentric stenoses changed 
lummal diameter dynamically in response to these vasoactive sub-
stances. 
NS). However, stenosis constnctlOn in response to er-
gonovine was, on average, significantly larger in eccentric 
than in concentric stenoses (19 ± 3 versus 9.5 ± 2, p < 0.05) 
(Fig. 3, Table 2). 
Response of eccentric and concentric stenoses to isosorbide 
dinitrate (Table 2). Intracoronary isosorbide dinitrate had 
no effect on mean aortic pressure or heart rate. Only 12 
(34%) of the 35 reference segments to concentric stenoses 
and 12 (40%) of the 30 reference segments to eccentric 
stenoses (p = NS) dilated 2: 10% with nitrate administration. 
Average coronary dilation was not significantly different in 
reference segments of concentric and eccentric stenoses 
(7.1 ± 3% and 10 ± 3%, respectively, p = NS) (Fig. 1). 
Seventy percent (21 of 30) of eccentric coronary stenoses 
and 43% (15 of 35) of concentric stenoses dilated by 2: 10% 
with the intracoronary administration of isosorbide dinitrate 
(p < 0.05) (Fig. 2). After intracoronary isosorbide dinitrate, 
the average coronary luminal diameter of eccentric stenoses 
increased by 18.6 ± 2.5% (from 1.15 ± 0.05 to 1.35 ± 
0.06 mm) and that of concentric stenoses increased by 10 ± 
Figure 3. Response of eccentric and concentric coronary stenoses 
to the administration of ergonovine and isosorbide dinitrate (ISDN). 
A significantly larger change in luminal diameter was documented in 
eccentric than in concentric coronary stenoses. 
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Table 3. Stenosis Morphology and Type of Angina in 51 Patients 
With Chronic Stable Angina 
Stenoses 
Angina Concentric Eccentric Both Types 
Mixed (n = 38) 18 (47%) 16 (42%) 4 (11%) 
Fixed threshold 5 (38%) 4 (31%) 4 (31%) 
(n = 13) 
2.5% (from 1.05 ± 0.05 to 1.14 ± 0.05 mm) (p < 0.05) (Table 
2, Fig. 3). Dilation of concentric coronary stenoses with 50% 
to 70% diameter reduction and that of stenoses with> 70% 
reduction was not significantly different (9.8 ± 4% and 12 ± 
5%, respectively). Similarly, the degree of vasodilation 
observed in eccentric coronary stenoses after isosorbide 
dinitrate was not significantly different in stenoses with 
:s70% and those with> 70% (17 ± 4 and 21.8 ± 3% diameter 
reduction, respectively). However, for any given degree of 
stenosis severity, dilation after isosorbide dinitrate was 
significantly greater in eccentric than in concentric coronary 
stenoses. In 31 of the 51 patients, isosorbide dinitrate was 
the only vasoactive substance tested, and in 20 it was given 
after ergonovine (2: 7 min after ergonovine in 16 patients and 
< 1 min of ergonovine in four). No significant differences 
were observed in the degree of stenosis vasodilation caused 
by isosorbide dinitrate, whether given alone or after er-
gonovine (15 ± 3 versus 12 ± 3%, respectively). 
Stenosis reactivity in patients who had both concentric and 
eccentric stenoses. In the eight patients found to have both 
concentric and eccentric coronary stenoses, isosorbide dini-
trate increased the coronary diameter of concentric stenoses 
by 9.7 ± 4% (from 1.08 ± 0.06 to 1.15 ± 0.07 mm) and that 
of eccentric stenoses by 19.2 ± 3% (from 1.10 ± 0.05 to 
1.32 ± 0.04 mm) (p < 0.05). Ergonovine reduced the luminal 
diameter of concentric stenoses in these patients by 10.2 ± 
3% (from 1.15 ± 0.06 to 1.03 ± 0.05 mm) and that of 
eccentric stenoses by 19.9 ± 2.5% (from 1.16 ± 0.04 to 0.95 
± 0.07 mm) (p < 0.05). 
Relation between stenosis morphology, stenosis reactivity 
and pattern of angina pectoris (Tables 3 and 4). The preva-
lence of concentric and eccentric stenoses was not signifi-
cantly different in patients with fixed angina threshold and 
variable threshold angina (mixed angina). Eighteen (47%) of 
the 38 patients with mixed angina had concentric, 16 had 
eccentric (42%) and 4 (11%) had both types of coronary 
stenoses. Of the 13 patients with a fixed angina threshold, 5 
Table 4. Dynamic Behavior of 65 Coronary Stenoses in Patients 
With Mixed Angina and in Patients With Fixed Threshold Angina 
Stenoses 
Concentric Eccentric Total 
Mixed angina (n = 46) 11/24; 46% 17122: 77% 28/46; 61% 
Fixed threshold (n = 19) 3/11; 27% 4/8; 50% 7119; 37% 
Total 14/35; 40% 21130; 70% 35/65; 54% 
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(38%) had concentric stenoses, 4 (31 %) had eccentric sten-
oses and 4 (31 %) had both concentric and eccentric stenoses 
(Table 3). A total of 65 coronary stenoses were analyzed; 46 
(22 eccentric and 24 concentric) in patients with mixed 
angina and 19 (8 eccentric and II concentric) in patients with 
fixed threshold angina (Table 4). In patients with mixed 
angina, 77% of eccentric stenoses and 46% of concentric 
stenoses showed changes in diameter ("dynamic behavior") 
in response to either isosorbide dinitrate or ergonovine (p = 
0.07), whereas in patients with fixed threshold angina, 50% 
of eccentric and 27% of concentric stenoses were dynamic 
(p = 0.6) (Table 4). Dynamic behavior was found in 28 (61%) 
of all 46 coronary stenoses analyzed in patients with mixed 
angina and in 7 (37%) of the 19 stenoses analyzed in patients 
with fixed anginal threshold (p = 0.13). Dynamic behavior 
was found in 77% of eccentric stenoses in patients with 
mixed angina and in 50% of eccentric stenoses in patients 
with fixed threshold angina (p = 0.3) (Table 4). The response 
of concentric stenoses did not differ significantly between 
patients with variable and those with fixed threshold angina. 
Discussion 
Our results indicate that in patients with chronic stable 
angina, not only eccentric coronary artery stenoses, which 
have an arc of vascular smooth muscle potentially able to 
react to vasoactive stimuli (14,15,20-22), but also concentric 
stenoses have the potential for dynamic changes of caliber in 
response to vasoactive stimuli. Our data also confirm that a 
significantly larger proportion of eccentric than concentric 
narrowings dilate with intracoronary nitrates and constrict 
with intracoronary or intravenous ergonovine. The magni-
tude of these changes of caliber in response to both isosor-
bide dinitrate and ergonovine was significantly larger in 
eccentric than in concentric stenoses. 
Reactivity of concentric and eccentric coronary stenosis. 
For the same degree of diameter reduction, vasomotility of 
eccentric stenoses was greater than that of concentric sten-
oses. These results are consistent with observations by 
Rafflenbeul et al. (9,16) with regard to the capacity of 
eccentric stenoses, compared with concentric stenoses, to 
dilate in response to nitrates and calcium antagonists. How-
ever, these investigators reported that eccentric stenoses, 
but not concentric lesions, dilated in response to calcium 
antagonists and nitrates. In our patients, although eccentric 
stenoses exhibited, on average, a larger vasomotor potential 
than did concentric stenoses, a substantial proportion of 
concentric stenoses also had the potential for vasomotor 
changes of coronary caliber. That concentric coronary sten-
oses also can be reactive structures is in agreement with 
results obtained by Ginsburg et al. (23) in isolated human 
epicardial coronary arteries. However, these investigators 
reported that in vitro, the contractile responses to vasoactive 
drugs were similar in segments with eccentric and concentric 
stenoses. 
The present study and studies of others (9,16,24) show 
that eccentric stenoses can more readily change their coro-
nary diameter than can concentric stenoses. This is probably 
because eccentric stenoses retain an arc of normal vascular 
smooth muscle (14) able to react to vasomotor stimuli, 
whereas concentric stenoses tend to be "fixed," as their 
vasomotility is limited by the involvement of the whole 
circumference of the artery in the atherosclerotic process. 
Less smooth muscle is available in concentric stenoses to 
respond to vasoactive stimuli (14). This is important because 
the extent to which dynamic augmentation or contraction of 
the coronary lumen is possible appears to be a function of 
the extent and location of smooth muscle in the coronary 
wall. Some angiographically concentric stenoses, however, 
may retain sufficient smooth muscle to enable them to 
constrict or dilate, as found in our study, when challenged 
with ergonovine or isosorbide dinitrate. Our results indicate 
that, on average, the morphologic appearance of a coronary 
lesion correlates with its ability to alter its caliber dynam-
ically, although there are many exceptions. Thus, in this 
study approximately 40% of concentric stenoses showed 
vasomotor potential and 20% of eccentric stenoses did not 
have such potential. Why some eccentric stenoses cannot 
react in response to vasodilator or constrictor stimuli is a 
matter of speculation, but may be related to the amount and 
distribution of the residual vascular smooth muscle and its 
functional capacity to react to vasoactive stimuli. 
The different behavior of eccentric and concentric sten-
oses observed in this study was not related to a different 
vasomotor capacity of the coronary tree in different patients, 
as reference segments to both eccentric and concentric 
stenoses exhibited a similar vasomotor response when chal-
lenged with ergonovine or after the administration of isosor-
bide dinitrate. Furthermore, we observed that within indi-
vidual patients the magnitude of changes of vasomotor tone 
was significantly larger in eccentric than in concentric sten-
oses. 
Severity of coronary stenosis and vascular reactivity. Our 
findings indicate that the different response of concentric and 
eccentric stenoses does not depend on the severity of the 
coronary atherosclerotic narrowing; stenosis severity (aver-
age diameter reduction) was similar in concentric and eccen-
tric stenoses. Indeed, the degree of response to ergonovine 
and nitrates was similar in concentric stenoses with ::;70% 
diameter reduction and concentric stenoses with >70% 
reduction. Eccentric stenoses with ::;70% diameter reduc-
tion and those with> 70% diameter reduction also showed a 
comparable response to nitrates and ergonovine. These 
findings are in agreement with those of Rafflenbeul et al. (9), 
who reported that "the chance for a beneficial response to 
nitrates is as good in a stenosis with high degree of obstruc-
tion as in a stenosis with low degree of obstruction," and 
with findings by Brown et al. (25), who observed that both 
mild and severe coronary stenoses can dilate with sublingual 
nitroglycerin. Our results are also consistent with those 
obtained by Saner et al. (14) with computerized planimetry. 
They observed that the percent of disease-free wall arc 
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length in eccentric stenoses did not differ significantly with 
increasing severity of coronary luminal obstruction. with 
location of the lesion within the same or different arteries. or 
among coronary segments with different diameters. 
Clinical implications. Although we did not find a signifi-
cant correlation between the pattern of angina and stenosis 
reactivity, there was clearly a trend for patients with a 
variable anginal threshold to have a larger proportion of 
dynamic stenoses than that of patients with a fixed anginal 
threshold. Limitations of this study did not allow accurate 
assessment of the relation between clinical presentation and 
stenosis reactivity; in particular. the fact that only 60% of all 
coronary lesions present in our patients were suitable for 
analysis and that a large proportion of patients had signifi-
cant two or three vessel disease. Occasionally. a patient had 
more than one type of stenosis, making it impossible. in 
some cases, to identify the coronary lesion responsible for 
the anginal symptoms. Furthermore. only a few patients in 
this study had a fixed exertional anginal threshold. Large 
series including consecutive patients with chronic stable 
angina and single vessel disease are needed to assess the 
correlation between clinical presentation and stenosis reac-
tivity and morphology. 
Assessing stenosis morphology and reactivity on an 
angiographic basis apparently is not a major problem. 
particularly with the new angiographic systems that allow 
imaging of the coronary arteries in mUltiple views, even 
during exercise (13). Quantitative information regarding the 
behavior of concentric and eccentric stenoses may help to 
explain the variable clinical presentations of chronic stable 
angina and may also provide the basis for rational antianginal 
therapy. 
The contribution of changes of coronary vasomotor tone 
to myocardial ischemia in patients with variable threshold 
angina is further suggested by the observation in some of our 
patients that stenosis vasoconstriction (not coronary spasm) 
induced by ergonovine caused transient myocardial ische-
mia. These observations are in agreement with the results of 
our previous studies (7,8,26-28) and those of other investi-
gators (6,9,10,13,16.29) that suggest that dynamic changes of 
caliber at the site of critical pliable coronary artery stenoses. 
whether concentric or eccentric. modulate the ischemic 
response of patients with chronic stable angina. Dynamic 
coronary stenoses, however, are not the only cause of mixed 
angina, as a variable anginal threshold has been observed 
also in patients who do not have the substratum for dynamic 
stenoses, such as those with an occluded coronary artery 
and collateral circulation arising from normal coronary ves-
sels (30). In these patients dynamic changes of small in-
tramyocardial and collateral vessels have been shown to be 
responsible for the variable angina threshold (30). 
We thank Jean Powell for preparing the illustrations for this manuscript. 
References 
1. Epstein SE. Talbot TL. Dynamic coronary tone in precipitation. exacer-
bation and relief of angina pectoris. Am J Cardiol 1981 ;48:797-803. 
2. Maseri A. The changing face of angina pectoris: practical implications. 
Lancet 1983; I : 746-9. 
3. Maseri A. Chierchia S. Kaski Je. Mixed angina pectoris. Am J Cardiol 
1985;56:30-33E. 
4. Stone P. Ware JH. De Wood MA. et al. The efficacy of the addition of 
nifedipine in patients with mixed angina compared to patients with classic 
exertional angina: a multicenter. randomized. double-blind. placebo-
controlled clinical trial. Am Heart J 1988;116:961-70. 
5. Brown BG. Coronary vasospasm: observations linking the clinical spec-
trum of ischemic heart disease to the dynamic pathology of coronary 
atherosclerosis. Arch Intern Med 1981:141:716-22. 
6. Brown BG. Bolson EL. Dodge HT. Dynamic mechanisms in human 
coronary stenosis. Circulation 1984:70:917-22. 
7. Crea F. Davies G. Romeo F. et al. Myocardial ischemia during er-
gonovine testing: different susceptibility to coronary vasoconstriction in 
patients with exertional and variant angina. Circulation 1984;69:690-5. 
8. Kaski Je. Rodriguez-Plaza L. Meran 00. Araujo L. Chierchia S. Maseri 
A. Improved coronary supply: the prevailing mechanism of action of 
nitrates in chronic stable angina. Am Heart J 1985; II 0:238-45. 
9. Rafflenbeul W. Urthaler F. Russel RO. Lichtlen P. James TN. Dilatation 
of coronary artery stenoses after isosorbide dinitrate in man. Br Heart J 
1980:43:546-9. 
10. Brown BG. Bolson EL. Petersen RB. Pierce CD. Dodge HT. The 
mechanism of nitroglycerin action: stenosis vasodilatation as a major 
component of the drug response. Circulation 1981 :64: 1089-97. 
11. Brown BG. Response of normal and diseased epicardial coronary arteries 
to vasoactive drugs: quantitative arteriographic studies. Am J Cardiol 
1985;56:23-9E. 
12. Serruys PW. Lablanche 1M. Reiber JHe. Bertrand ME. Hugenholtz PG. 
Contribution of dynamic vascular wall thickening to luminal narrowing 
during arterial vasomotion. Z Kardiol 1983:72(supp1.3): 116-23. 
13. Gage lE. Hess OM. Murakami T. Ritter M. Grimm l. Krayenbuehl HP. 
Vasoconstriction of stenotic coronary arteries during dynamic exercise in 
patients with classic angina pectoris: reversibility by nitroglycerin. Cir-
culation 1986;73:865-76. 
14. Saner HE. Gobel FL. Salomonowitz E. Erlein DA. Edwards JE. The 
disease-free wall in coronary atherosclerosis: its relation to degree of 
obstruction. 1 Am Coli Cardiol 1985:6: 1096-9. 
15. Waller BF. The eccentric coronary atherosclerotic plaque: morphologic 
observations and clinical relevance. Clin Cardiol 1989: 12: 14-20. 
16. Rafflenbeul W. Lichtlen PRo Quantitative coronary angiography: evi-
dence of a sustained increase in vascular smooth muscle tone in coronary 
artery stenosis. Z Kardiol 1983:72(suppl III):87-91. 
17. MacAlpin RN. Contribution of dynamic vascular wall thickening to 
luminal narrowing during coronary arterial constriction. Circulation 1980; 
61:296-301. 
18. Hackett D. Larkin S. Chierchia S. Davies G. Kaski JC. Maseri A. 
Induction of coronary artery spasm by a direct local action of ergonovine. 
Circulation 1987 :75:577-82. 
19. Reiber JHe. Serruys PW. Koouman C. et al. Assessment of short-. 
medium-. and long-term variations in arterial dimensions from computer-
assisted quantitation of coronary cineangiograms. Circulation 1985;71: 
280-8. 
20. Vlodaver Z. Edwards lE. Pathology of coronary atherosclerosis. Progr 
Cardiovasc Dis 1971;14:256-74. 
21. Freudenberg H. Licht1en PRo The normal wall segment in coronary 
stenosis: a postmortem study. Z Kardiol 1981 ;70:863-9. 
22. Davies Ml. Thomas Ae. Plaque fissuring: the cause of acute myocardial 
infarction. sudden ischaemic death and crescendo angina. Br Heart 1 
1985 ;53:363-73. 
23. Ginsburg R. Bristow MR. Davies K. Dibiase A. Billingham ME. Quanti-
tative pharmacologic responses of normal and atherosclerotic isolated 
human epicardial coronary arteries. Circulation 1984;69:430-40. 
24. Logan SE. On the fluid mechanics of human coronary artery stenosis. 
lEE Trans Biomed Eng BME 1975;22:327-37. 
KASKI ET AL. 633 JACC Vol. 17, No.3 
March I, 1991:627-33 REACTIVITY OF CONCENTRIC AND ECCENTRIC STENOSES 
25. Brown BG. Bolson E, Petersen RB, Pierce CD, Dodge HT. The mecha-
nisms of nitroglycerin action: stenosis vasodilatation as a major compo-
nent to the drug response. Circulation 1981 :64: 1089-97. 
26. Crea F. Margonato A. Kaski JC, et al. Variability of results during repeat 
exercise stress testing in patients with stable angina pectoris: role of 
dynamic coronary flow reserve. Am Heart J 1986:112:249-54. 
27. Crea F. Davies G. Chierchia S. et al. Different susceptibility to myocar-
dial ischemia provoked by hyperventilation and cold pressor test in 
exertional and variant angina pectoris. Am J Cardiol 1985;56: 18-22. 
28. Pupita G. Kaski JC, Galassi AR. Vejar M, Crea F. Maseri A. Ischemic 
threshold varies in response to different types of exercise in patients with 
chronic stable angina. Am Heart J 1989;118:539-44. 
29. Ichikawa Y. Yokoyama M. Akita H. Fukuzaki H. Constriction of large 
coronary artery contributes to serotonin-induced myocardial ischemia in 
the dog with pliable coronary artery stenosis. J Am Coli CardioI1989;14: 
449-59. 
30. Pupita G. Maseri A. Kaski Jc. et al. Myocardial ischemia caused by distal 
coronary artery constriction in stable angina pectoris. N Engl J Med 
1990;323:514-20. 
